Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma

被引:84
作者
Mitani, N [1 ]
Murakami, K [1 ]
Yamaura, T [1 ]
Ikeda, T [1 ]
Saiki, I [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Inst Nat Med, Dept Pathogen Biochem, Toyama 9300194, Japan
关键词
Lewis lung carcinoma; lymph node metastasis; berberine; 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxy-camptothecin (CPT-11); activator protein-1 (AP-1);
D O I
10.1016/S0304-3835(00)00710-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We examined the effect of berberine, a major component with anti-fungal properties contained in Coptidis Rhizoma and Phellodendri Cortex, on the lymph node metastasis of murine lung cancer. Oral administration of berberine for 14 days significantly inhibited the spontaneous mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma (LLC) into the lung parenchyma in a dose-dependent manner, but did not affect the tumor growth at the implantation site of the lung. Combined treatment with berberine and an anti-cancer drug, CPT-11, resulted in a marked inhibition of tumor growth at the implantation site and of lymphatic metastasis, as compared with either treatment alone. Antiactivator protein-1 (anti-AP-1) transcriptional activity of non-cytotoxic concentrations of berberine caused the inhibition of the invasiveness of LLC cells through the repression of expression of urokinase-type plasminogen activator (u-PA). (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 41 条
[1]   IRINOTECAN (CPT-11) HIGH-DOSE ESCALATION USING INTENSIVE HIGH-DOSE LOPERAMIDE TO CONTROL DIARRHEA [J].
ABIGERGES, D ;
ARMAND, JP ;
CHABOT, GG ;
DACOSTA, L ;
FADEL, E ;
COTE, C ;
HERAIT, P ;
GANDIA, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (06) :446-449
[2]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[3]  
2-Z
[4]   BIOCHEMICAL EFFECTS OF BERBERINE [J].
CREASEY, WA .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (07) :1081-1084
[5]   FOS AND JUN - THE AP-1 CONNECTION [J].
CURRAN, T ;
FRANZA, BR .
CELL, 1988, 55 (03) :395-397
[6]  
DeCesare D, 1996, ONCOGENE, V13, P2551
[7]   Mediastinal lymph node metastasis model by orthotopic intrapulmonary implantation of Lewis lung carcinoma cells in mice [J].
Doki, Y ;
Murakami, K ;
Yamaura, T ;
Sugiyama, S ;
Misaki, T ;
Saiki, I .
BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) :1121-1126
[8]   PLASMINOGEN-ACTIVATOR AND CANCER [J].
DUFFY, MJ ;
OGRADY, P .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (05) :577-582
[9]  
FASIOLI F, 1994, TRENDS PHARMACOL SCI, V15, P25
[10]  
FOLKMAN J, 1997, CANC PRINCIPLES PRAC, V2, P3075